HLTRFHLS Therapeutics Inc.
Oct 22, 2026 — H2 Commercial Pipeline & Revenue Update
Chart by TradingViewThe schedule
- Thu22Oct
Interim update on commercial execution and potential specialty drug partnerships.
- Mon25Jan
Management's forward guidance for FY27, including potential debt restructuring or M&A actions.
- Fri26Feb
Q3 2026 financial results assessing the debt-to-equity ratio and generic drug sales momentum.
- Fri28May
Full year 2026 earnings report and formal 2027 revenue guidance.
- Fri27Aug
Past
- Fri28Aug
Estimated Q2 2026 financial results, focusing on top-line growth trajectory and operating cash flow durability.